实用肿瘤学杂志 ›› 2015, Vol. 29 ›› Issue (2): 136-139.doi: 10.11904/j.issn.1002-3070.2015.02.009

• 综述 • 上一篇    下一篇

胶质母细胞瘤经典亚型特征性基因变异的研究进展

刘恩瑞1,任欢1,赵宇1(综述),苏君2(审校)   

  1. 1.哈尔滨医科大学免疫教研室(哈尔滨 150081);
    2.哈尔滨医科大学附属肿瘤医院神经外科
  • 收稿日期:2014-09-03 出版日期:2015-04-28 发布日期:2015-05-05
  • 通讯作者: 苏君,E-mail:sujun6686@126.com E-mail:sujun6686@126.com
  • 作者简介:刘恩瑞,男,(1992-),硕士研究生,从事胶质瘤的分子生物学特征方面的研究
  • 基金资助:
    国家自然科学基金重大项目培育项目(NSFC 91229112);黑龙江省科技攻关项目(GC12C303-1)

Advanced research on characteristics of the classical subtype of human glioblastoma

LIU Enrui1,REN Huan1,ZHAO Yu1,SU Jun2   

  1. 1.Department of Immunology,Harbin Medical University,Harbin 150081,China;
    2.Department of Neurosurgery,Harbin Medical University Cancer Hospital
  • Received:2014-09-03 Online:2015-04-28 Published:2015-05-05

摘要: 目的 胶质母细胞瘤(Glioblastoma,GBM)是颅内最常见的原发恶性肿瘤,其恶性程度高、侵袭能力强、预后差。近年来随着生物学技术的发展,对GBM的理解也从病理学诊断逐步转向分子病理机制的研究。根据基因表达和DNA甲基化的模式将原发性GBM分为经典型、间质型、前神经元型和神经元型四种亚型。这些分子分型与胶质母细胞瘤的生物学特性密切相关。本文简要介绍了原发胶质母细胞瘤的分子分型,重点关注经典型GBM中EGFR、PTEN、PI3K和CDKN2A四种特征性基因的变异情况,并且对经典型胶质母细胞瘤的治疗策略进行了探讨。

Abstract: Glioblastoma(GBM)is one of the most common primary intracranial tumor that has high degree of malignancy,invasive ability and a fatal prognosis.In recent years,with the development of modern technology in biomedical sciences,the understanding on GBM has developed gradually from pathological diagnosis to molecular classifications,which is based on the molecular characteristics of genetic signatures.Based on gene expression and DNA methylation patterns,primary glioblastoma is divided into four subtypes,including the classical,neural,proneural and mesenchymal.These molecular classifications are closely relevant to the biological characteristics of glioblastoma.This review briefly introduces the molecular classifications of primary glioblastoma,but mainly focuses on the changes of the major genetic EGFR,PTEN and PI3K,CDKN2A in the classical subtype of GBM,and discusses the treatment strategies for primary glioblastoma.

中图分类号: